6种检查诊断轻微肝性脑病及预测临床结局的比较:前瞻性观察研究
结果显示诊断应基于校正常模值,各检查不能等同,对临床结局预测价值总体有限。
要点
- 轻微肝性脑病诊断应基于校正常模值而非固定截断值。
- 6种检查结果间不能相互等同,预测临床结局价值有限。
- 仅异常PHES结果与oHE发展相关,其他校正后检查无预测价值。
核心结论
- 在适用情况下,轻微肝性脑病的诊断应仅基于检查的校正常模值。
- 轻微肝性脑病检查之间不能相互等同,对临床结局的预测价值总体有限。
主要发现
- 109例无神经损伤患者中,35.8%有异常PHES,44%有异常CRT。
- 使用校正常模值后,Stroop(79.8% vs. 52.3%)、ANT(19.3% vs. 51.4%)、ICT(28.4% vs. 36.7%)和CFF(18.3% vs. 25.7%)异常百分比显著变化。
- 除CFF外,所有检查结果相互显著相关(p<0.05)。
- 随访期间24例发生oHE,58例再住院,20例死亡。
- 多变量模型中,异常PHES结果与oHE发展相关,其他校正后检查对任何终点无预测价值。
临床怎么用
- 临床诊断轻微肝性脑病应使用校正常模值评估检查结果。
- 不应将不同轻微肝性脑病检查结果相互等同或替换使用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Current guidelines recommend the assessment for minimal HE in patients with liver cirrhosis. Various efforts were made to find tools that simplify the diagnosis. Here, we compare the 6 most frequently used tests for their validity and their predictive value for overt hepatic encephalopathy (oHE), rehospitalization, and death. APPROACH AND RESULTS: One hundred thirty-two patients with cirrhosis underwent the Portosystemic Encephalopathy-Syndrome-Test yielding the psychometric hepatic encephalopathy score (PHES), Animal Naming Test (ANT), Critical Flicker Frequency (CFF), Inhibitory Control Test (ICT), EncephalApp (Stroop), and Continuous Reaction Time Test (CRT). Patients were monitored for 365 days regarding oHE development, rehospitalization, and death. Twenty-three patients showed clinical signs of HE grade 1-2 at baseline. Of the remaining 109 neurologically unimpaired patients, 35.8% had abnormal PHES and 44% abnormal CRT. Percentage of abnormal Stroop (79.8% vs. 52.3%), ANT (19.3% vs. 51.4%), ICT (28.4% vs. 36.7%), and CFF results (18.3% vs. 25.7%) changed significantly when adjusted norms were used for evaluation instead of fixed cutoffs. All test results correlated significantly with each other ( p <0.05), except for CFF. During follow-up, 24 patients developed oHE, 58 were readmitted to the hospital, and 20 died. Abnormal PHES results were linked to oHE development in the multivariable model. No other adjusted test demonstrated predictive value for any of the investigated endpoints. CONCLUSIONS: Where applicable, the diagnosis of minimal HE should be made based on adjusted norm values for the tests, exclusively. The minimal HE tests cannot be equated with one another and have an overall limited value in predicting clinical outcomes.
引用
- Ehrenbauer AF, Egge JFM, Gabriel MM, et al. Comparison of 6 tests for diagnosing minimal hepatic encephalopathy and predicting clinical outcome: A prospective, observational study. Hepatology. 2024. PMID: 38349709. doi:10.1097/HEP.0000000000000770
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。